Literature DB >> 33542268

Clinically-identified C-terminal mutations in fibulin-3 are prone to misfolding and destabilization.

DaNae R Woodard1, Emi Nakahara1, John D Hulleman2,3.   

Abstract

Distinct mutations in the secreted extracellular matrix protein, fibulin-3 (F3), have been associated with a number of ocular diseases ranging from primary open angle glaucoma to cuticular age-related macular degeneration to a rare macular dystrophy, Malattia Leventinese (ML). The R345W F3 mutation that causes ML leads to F3 misfolding, inefficient secretion and accumulation at higher intracellular steady state levels in cultured cells. Herein, we determined whether fifteen other clinically-identified F3 mutations also led to similar levels of misfolding and secretion defects, which might provide insight into their potential pathogenicity. Surprisingly, we found that only a single F3 variant, L451F, presented with a significant secretion defect (69.5 ± 2.4% of wild-type (WT) F3 levels) and a corresponding increase in intracellular levels (226.8 ± 25.4% of WT F3 levels). Upon follow-up studies, when this conserved residue (L451) was mutated to a charged (Asp or Arg) or bulky (Pro, Trp, Tyr) residue, F3 secretion was also compromised, indicating the importance of small side chains (Leu, Ala, or Gly) at this residue. To uncover potential inherent F3 instability not easily observed under typical culture conditions, we genetically eliminated the sole stabilizing N-linked glycosylation site (N249) from select clinically-identified F3 mutants. This removal exacerbated R345W and L451F secretion defects (19.8 ± 3.0% and 12.4 ± 1.2% of WT F3 levels, respectively), but also revealed a previously undiscovered secretion defect in another C-terminal variant, Y397H (42.0 ± 10.1% of WT F3 levels). Yet, glycan removal did not change the relative secretion of the N-terminal mutants tested (D49A, R140W, I220F). These results highlight the uniqueness and molecular similarities between the R345W and L451F variants and also suggest that previously identified disease-associated mutations (e.g., R140W) are indistinguishable from WT with respect to secretion, hinting that they may lead to disease by an alternative mechanism.

Entities:  

Year:  2021        PMID: 33542268     DOI: 10.1038/s41598-020-79570-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  41 in total

Review 1.  Ageing changes in the eye.

Authors:  S M Salvi; S Akhtar; Z Currie
Journal:  Postgrad Med J       Date:  2006-09       Impact factor: 2.401

2.  Global causes of vision loss in 2015: are we on track to achieve the Vision 2020 target?

Authors:  Charumathi Sabanayagam; Ching-Yu Cheng
Journal:  Lancet Glob Health       Date:  2017-10-11       Impact factor: 26.763

Review 3.  Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex.

Authors:  Imran Bhutto; Gerard Lutty
Journal:  Mol Aspects Med       Date:  2012-04-21

Review 4.  Age-related macular degeneration--emerging pathogenetic and therapeutic concepts.

Authors:  Karen M Gehrs; Don H Anderson; Lincoln V Johnson; Gregory S Hageman
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

5.  Visual Impairment and Blindness in Adults in the United States: Demographic and Geographic Variations From 2015 to 2050.

Authors:  Rohit Varma; Thasarat S Vajaranant; Bruce Burkemper; Shuang Wu; Mina Torres; Chunyi Hsu; Farzana Choudhury; Roberta McKean-Cowdin
Journal:  JAMA Ophthalmol       Date:  2016-07-01       Impact factor: 7.389

Review 6.  Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.

Authors:  Wan Ling Wong; Xinyi Su; Xiang Li; Chui Ming G Cheung; Ronald Klein; Ching-Yu Cheng; Tien Yin Wong
Journal:  Lancet Glob Health       Date:  2014-01-03       Impact factor: 26.763

Review 7.  Mechanisms of age-related macular degeneration.

Authors:  Jayakrishna Ambati; Benjamin J Fowler
Journal:  Neuron       Date:  2012-07-12       Impact factor: 17.173

8.  Age and disease-related structural changes in the retinal pigment epithelium.

Authors:  Vera L Bonilha
Journal:  Clin Ophthalmol       Date:  2008-06

Review 9.  Recent advances in the management and understanding of macular degeneration.

Authors:  Sepehr Bahadorani; Michael Singer
Journal:  F1000Res       Date:  2017-04-20

Review 10.  A glimpse at the aging eye.

Authors:  Jonathan B Lin; Kazuo Tsubota; Rajendra S Apte
Journal:  NPJ Aging Mech Dis       Date:  2016-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.